Novo Nordisk loses two senior staff to alternative antibiotics firm

Swiss biotech company Micreos Pharmaceuticals, which is developing alternatives to antibiotics, has succeeded in its hunt for new upper-level employees for two newly established roles, poaching two employees from Novo Nordisk.
Carsten Edwards and Trine Ahlgreen | Photo: Micreos Pharmaceuticals / PR
Carsten Edwards and Trine Ahlgreen | Photo: Micreos Pharmaceuticals / PR
by albert rønning-andersson, translated by daniel pedersen

Swiss Micreos Pharmaceuticals, which develops new biological therapies against unwanted bacteria within a number of indications, has announced the hires for two new positions, chief business officer and chief development officer, a company press release reports.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading